Kalpit Patel

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Kalpit Patel works at B. Riley and is focused on the Healthcare sector with 75 price targets and ratings documented since 2021 spanning on 12 stocks. Analyst's average stock valuation to be materialised ratio is 16.94% with an average time for price targets to be met of 7.75 days.

Most recent stock forecast was given on MRTX, Mirati Therapeutics, Inc at 23-Jan-2023.

Kalpit Patel best performing recommendations are on FBRX.
The best stock recommendation documented was for BCYC (BICYCLE THERAPEUTICS PLC) at 10/1/2021. The price target of $56 was fulfilled within 12 days with a profit of $11.48 (25.79%) receiving and performance score of 21.49.

Average potential price target upside

Currently, out of the existing stock ratings of Kalpit Patel - 3623 which are a Buy (77.51%), 1051 which are a Hold (22.49%)

BCYC INFI INKT KYMR MGTA RIGL FBRX ALLO ENTX INAB VINC MRTX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

57

$36.45 (177.37%)

57

26 days ago

3/7 (42.86%)

$19.36 (79.72%)

146

Buy

67

$46.45 (226.03%)

72

26 days ago

0/6 (0%)

$40.64 (131.63%)

Buy

48

$27.45 (133.58%)

37

4 months 17 days ago

5/9 (55.56%)

$18.14 (83.78%)

296

Buy

46

$25.45 (123.84%)

70

4 months 18 days ago

2/5 (40%)

$18.35 (50.62%)

95

Hold

45

$24.45 (118.98%)

45

6 months 15 days ago

1/3 (33.33%)

$10.85 (35.43%)

24

Show more analysts
BCYC INFI INKT KYMR MGTA RIGL FBRX ALLO ENTX INAB VINC MRTX